Top of the morning to you, and a fine one it is. ‘Tis easy to ignore the gloomy skies hovering over the Pharmalot campus, since we are reciting one of our favorite mantras: Every brand new day should be unwrapped like a precious gift (hat tip to the Morning Mayor). So we will reach for another cup of stimulation — we are trying caramel cream today, for those tracking this sort of thing — you can tug on the ribbon and explore the tidbits below. Have a smashing day and, of course, do keep in touch …
Which drug maker is most vulnerable to the aftermath of Hurricane Maria in Puerto Rico? Well, AbbVie (ABBV) derives about 72 percent of its U.S. prescription drugs sales from products made, in whole or in part, on the island, according to Sector & Sovereign Research. Amgen (AMGN) is a close second at 67 percent. Not surprisingly, many companies are still running below capacity, according to STAT.
About the Author Reprints
At Q3 2017 end, Lilly’s headcount had a drastic reduction compared to Q3 of 2016. http://alph.st/bcbcba96